1. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor. Issue 1 (December 2015) Authors: Nishimura, Toshio; Nakamura, Kazuto; Yamashita, Soichi; Ikeda, Sadatomo; Kigure, Keiko; Minegishi, Takashi Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗